This report aims to provide a comprehensive presentation of the global market for Influenza Drugs and Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Drugs and Vaccines. This report contains market size and forecasts of Influenza Drugs and Vaccines in global, including the following market information:
Global Influenza Drugs and Vaccines Market Revenue, 2019-2024, 2024-2029, ($ millions)
Global Influenza Drugs and Vaccines Market Sales, 2019-2024, 2024-2029, (MT)
Global top five Influenza Drugs and Vaccines companies in 2023 (%)
The global Influenza Drugs and Vaccines market was valued at US$ million in 2023 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Influenza Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Influenza Drugs and Vaccines include Bristol Myers Squibb, AstraZeneca, Eli Lilly, Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur and Bayer, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Influenza Drugs and Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Influenza Drugs and Vaccines Market, by Type, 2019-2024, 2024-2029 ($ Millions) & (MT)
Global Influenza Drugs and Vaccines Market Segment Percentages, by Type, 2023 (%)
Influenza Drugs
Influenza Vaccines
Global Influenza Drugs and Vaccines Market, by Application, 2019-2024, 2024-2029 ($ Millions) & (MT)
Global Influenza Drugs and Vaccines Market Segment Percentages, by Application, 2023 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Influenza Drugs and Vaccines Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions) & (MT)
Global Influenza Drugs and Vaccines Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Influenza Drugs and Vaccines revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Influenza Drugs and Vaccines revenues share in global market, 2023 (%)
Key companies Influenza Drugs and Vaccines sales in global market, 2019-2024 (Estimated), (MT)
Key companies Influenza Drugs and Vaccines sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol Myers Squibb
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Influenza Drugs and Vaccines, market overview.
Chapter 2: Global Influenza Drugs and Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Influenza Drugs and Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Influenza Drugs and Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Influenza Drugs and Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Influenza Drugs and Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Influenza Drugs and Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Influenza Drugs and Vaccines Overall Market Size
2.1 Global Influenza Drugs and Vaccines Market Size: 2022 VS 2031
2.2 Global Influenza Drugs and Vaccines Revenue, Prospects & Forecasts: 2019-2031
2.3 Global Influenza Drugs and Vaccines Sales: 2019-2031
3 Company Landscape
3.1 Top Influenza Drugs and Vaccines Players in Global Market
3.2 Top Global Influenza Drugs and Vaccines Companies Ranked by Revenue
3.3 Global Influenza Drugs and Vaccines Revenue by Companies
3.4 Global Influenza Drugs and Vaccines Sales by Companies
3.5 Global Influenza Drugs and Vaccines Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Influenza Drugs and Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Influenza Drugs and Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Influenza Drugs and Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Influenza Drugs and Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Influenza Drugs and Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Influenza Drugs and Vaccines Market Size Markets, 2022 & 2031
4.1.2 Influenza Drugs
4.1.3 Influenza Vaccines
4.2 By Type - Global Influenza Drugs and Vaccines Revenue & Forecasts
4.2.1 By Type - Global Influenza Drugs and Vaccines Revenue, 2019-2024
4.2.2 By Type - Global Influenza Drugs and Vaccines Revenue, 2024-2031
4.2.3 By Type - Global Influenza Drugs and Vaccines Revenue Market Share, 2019-2031
4.3 By Type - Global Influenza Drugs and Vaccines Sales & Forecasts
4.3.1 By Type - Global Influenza Drugs and Vaccines Sales, 2019-2024
4.3.2 By Type - Global Influenza Drugs and Vaccines Sales, 2024-2031
4.3.3 By Type - Global Influenza Drugs and Vaccines Sales Market Share, 2019-2031
4.4 By Type - Global Influenza Drugs and Vaccines Price (Manufacturers Selling Prices), 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Influenza Drugs and Vaccines Market Size, 2022 & 2031
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Application - Global Influenza Drugs and Vaccines Revenue & Forecasts
5.2.1 By Application - Global Influenza Drugs and Vaccines Revenue, 2019-2024
5.2.2 By Application - Global Influenza Drugs and Vaccines Revenue, 2024-2031
5.2.3 By Application - Global Influenza Drugs and Vaccines Revenue Market Share, 2019-2031
5.3 By Application - Global Influenza Drugs and Vaccines Sales & Forecasts
5.3.1 By Application - Global Influenza Drugs and Vaccines Sales, 2019-2024
5.3.2 By Application - Global Influenza Drugs and Vaccines Sales, 2024-2031
5.3.3 By Application - Global Influenza Drugs and Vaccines Sales Market Share, 2019-2031
5.4 By Application - Global Influenza Drugs and Vaccines Price (Manufacturers Selling Prices), 2019-2031
6 Sights by Region
6.1 By Region - Global Influenza Drugs and Vaccines Market Size, 2022 & 2031
6.2 By Region - Global Influenza Drugs and Vaccines Revenue & Forecasts
6.2.1 By Region - Global Influenza Drugs and Vaccines Revenue, 2019-2024
6.2.2 By Region - Global Influenza Drugs and Vaccines Revenue, 2024-2031
6.2.3 By Region - Global Influenza Drugs and Vaccines Revenue Market Share, 2019-2031
6.3 By Region - Global Influenza Drugs and Vaccines Sales & Forecasts
6.3.1 By Region - Global Influenza Drugs and Vaccines Sales, 2019-2024
6.3.2 By Region - Global Influenza Drugs and Vaccines Sales, 2024-2031
6.3.3 By Region - Global Influenza Drugs and Vaccines Sales Market Share, 2019-2031
6.4 North America
6.4.1 By Country - North America Influenza Drugs and Vaccines Revenue, 2019-2031
6.4.2 By Country - North America Influenza Drugs and Vaccines Sales, 2019-2031
6.4.3 US Influenza Drugs and Vaccines Market Size, 2019-2031
6.4.4 Canada Influenza Drugs and Vaccines Market Size, 2019-2031
6.4.5 Mexico Influenza Drugs and Vaccines Market Size, 2019-2031
6.5 Europe
6.5.1 By Country - Europe Influenza Drugs and Vaccines Revenue, 2019-2031
6.5.2 By Country - Europe Influenza Drugs and Vaccines Sales, 2019-2031
6.5.3 Germany Influenza Drugs and Vaccines Market Size, 2019-2031
6.5.4 France Influenza Drugs and Vaccines Market Size, 2019-2031
6.5.5 U.K. Influenza Drugs and Vaccines Market Size, 2019-2031
6.5.6 Italy Influenza Drugs and Vaccines Market Size, 2019-2031
6.5.7 Russia Influenza Drugs and Vaccines Market Size, 2019-2031
6.5.8 Nordic Countries Influenza Drugs and Vaccines Market Size, 2019-2031
6.5.9 Benelux Influenza Drugs and Vaccines Market Size, 2019-2031
6.6 Asia
6.6.1 By Region - Asia Influenza Drugs and Vaccines Revenue, 2019-2031
6.6.2 By Region - Asia Influenza Drugs and Vaccines Sales, 2019-2031
6.6.3 China Influenza Drugs and Vaccines Market Size, 2019-2031
6.6.4 Japan Influenza Drugs and Vaccines Market Size, 2019-2031
6.6.5 South Korea Influenza Drugs and Vaccines Market Size, 2019-2031
6.6.6 Southeast Asia Influenza Drugs and Vaccines Market Size, 2019-2031
6.6.7 India Influenza Drugs and Vaccines Market Size, 2019-2031
6.7 South America
6.7.1 By Country - South America Influenza Drugs and Vaccines Revenue, 2019-2031
6.7.2 By Country - South America Influenza Drugs and Vaccines Sales, 2019-2031
6.7.3 Brazil Influenza Drugs and Vaccines Market Size, 2019-2031
6.7.4 Argentina Influenza Drugs and Vaccines Market Size, 2019-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Influenza Drugs and Vaccines Revenue, 2019-2031
6.8.2 By Country - Middle East & Africa Influenza Drugs and Vaccines Sales, 2019-2031
6.8.3 Turkey Influenza Drugs and Vaccines Market Size, 2019-2031
6.8.4 Israel Influenza Drugs and Vaccines Market Size, 2019-2031
6.8.5 Saudi Arabia Influenza Drugs and Vaccines Market Size, 2019-2031
6.8.6 UAE Influenza Drugs and Vaccines Market Size, 2019-2031
7 Manufacturers & Brands Profiles
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Company Summary
7.1.2 Bristol Myers Squibb Business Overview
7.1.3 Bristol Myers Squibb Influenza Drugs and Vaccines Major Product Offerings
7.1.4 Bristol Myers Squibb Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.1.5 Bristol Myers Squibb Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Influenza Drugs and Vaccines Major Product Offerings
7.2.4 AstraZeneca Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Influenza Drugs and Vaccines Major Product Offerings
7.3.4 Eli Lilly Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Influenza Drugs and Vaccines Major Product Offerings
7.4.4 Roche Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.4.5 Roche Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Influenza Drugs and Vaccines Major Product Offerings
7.5.4 GlaxoSmithKline Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Influenza Drugs and Vaccines Major Product Offerings
7.6.4 Novartis Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.6.5 Novartis Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Influenza Drugs and Vaccines Major Product Offerings
7.7.4 Pfizer Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.7.5 Pfizer Key News & Latest Developments
7.8 Sanofi Pasteur
7.8.1 Sanofi Pasteur Company Summary
7.8.2 Sanofi Pasteur Business Overview
7.8.3 Sanofi Pasteur Influenza Drugs and Vaccines Major Product Offerings
7.8.4 Sanofi Pasteur Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.8.5 Sanofi Pasteur Key News & Latest Developments
7.9 Bayer
7.9.1 Bayer Company Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Influenza Drugs and Vaccines Major Product Offerings
7.9.4 Bayer Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.9.5 Bayer Key News & Latest Developments
7.10 Celgene
7.10.1 Celgene Company Summary
7.10.2 Celgene Business Overview
7.10.3 Celgene Influenza Drugs and Vaccines Major Product Offerings
7.10.4 Celgene Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.10.5 Celgene Key News & Latest Developments
7.11 Seqirus
7.11.1 Seqirus Company Summary
7.11.2 Seqirus Influenza Drugs and Vaccines Business Overview
7.11.3 Seqirus Influenza Drugs and Vaccines Major Product Offerings
7.11.4 Seqirus Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.11.5 Seqirus Key News & Latest Developments
7.12 Protein Sciences Corporation
7.12.1 Protein Sciences Corporation Company Summary
7.12.2 Protein Sciences Corporation Influenza Drugs and Vaccines Business Overview
7.12.3 Protein Sciences Corporation Influenza Drugs and Vaccines Major Product Offerings
7.12.4 Protein Sciences Corporation Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.12.5 Protein Sciences Corporation Key News & Latest Developments
7.13 Serum Institute of India
7.13.1 Serum Institute of India Company Summary
7.13.2 Serum Institute of India Influenza Drugs and Vaccines Business Overview
7.13.3 Serum Institute of India Influenza Drugs and Vaccines Major Product Offerings
7.13.4 Serum Institute of India Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.13.5 Serum Institute of India Key News & Latest Developments
7.14 Emergent Biosolutions
7.14.1 Emergent Biosolutions Company Summary
7.14.2 Emergent Biosolutions Business Overview
7.14.3 Emergent Biosolutions Influenza Drugs and Vaccines Major Product Offerings
7.14.4 Emergent Biosolutions Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.14.5 Emergent Biosolutions Key News & Latest Developments
7.15 BioCryst Pharmaceuticals
7.15.1 BioCryst Pharmaceuticals Company Summary
7.15.2 BioCryst Pharmaceuticals Business Overview
7.15.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Major Product Offerings
7.15.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.15.5 BioCryst Pharmaceuticals Key News & Latest Developments
7.16 Alvogen
7.16.1 Alvogen Company Summary
7.16.2 Alvogen Business Overview
7.16.3 Alvogen Influenza Drugs and Vaccines Major Product Offerings
7.16.4 Alvogen Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.16.5 Alvogen Key News & Latest Developments
8 Global Influenza Drugs and Vaccines Production Capacity, Analysis
8.1 Global Influenza Drugs and Vaccines Production Capacity, 2019-2031
8.2 Influenza Drugs and Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Influenza Drugs and Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Influenza Drugs and Vaccines Supply Chain Analysis
10.1 Influenza Drugs and Vaccines Industry Value Chain
10.2 Influenza Drugs and Vaccines Upstream Market
10.3 Influenza Drugs and Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Influenza Drugs and Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Influenza Drugs and Vaccines in Global Market
Table 2. Top Influenza Drugs and Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Influenza Drugs and Vaccines Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Influenza Drugs and Vaccines Revenue Share by Companies, 2019-2024
Table 5. Global Influenza Drugs and Vaccines Sales by Companies, (MT), 2019-2024
Table 6. Global Influenza Drugs and Vaccines Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Influenza Drugs and Vaccines Price (2019-2024) & (USD/Kg)
Table 8. Global Manufacturers Influenza Drugs and Vaccines Product Type
Table 9. List of Global Tier 1 Influenza Drugs and Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Influenza Drugs and Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Influenza Drugs and Vaccines Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Global Influenza Drugs and Vaccines Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Influenza Drugs and Vaccines Revenue (US$, Mn), 2024-2031
Table 14. By Type - Global Influenza Drugs and Vaccines Sales (MT), 2019-2024
Table 15. By Type - Global Influenza Drugs and Vaccines Sales (MT), 2024-2031
Table 16. By Application ? Global Influenza Drugs and Vaccines Revenue, (US$, Mn), 2022 & 2031
Table 17. By Application - Global Influenza Drugs and Vaccines Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Influenza Drugs and Vaccines Revenue (US$, Mn), 2024-2031
Table 19. By Application - Global Influenza Drugs and Vaccines Sales (MT), 2019-2024
Table 20. By Application - Global Influenza Drugs and Vaccines Sales (MT), 2024-2031
Table 21. By Region ? Global Influenza Drugs and Vaccines Revenue, (US$, Mn), 2022 VS 2031
Table 22. By Region - Global Influenza Drugs and Vaccines Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Influenza Drugs and Vaccines Revenue (US$, Mn), 2024-2031
Table 24. By Region - Global Influenza Drugs and Vaccines Sales (MT), 2019-2024
Table 25. By Region - Global Influenza Drugs and Vaccines Sales (MT), 2024-2031
Table 26. By Country - North America Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Influenza Drugs and Vaccines Revenue, (US$, Mn), 2024-2031
Table 28. By Country - North America Influenza Drugs and Vaccines Sales, (MT), 2019-2024
Table 29. By Country - North America Influenza Drugs and Vaccines Sales, (MT), 2024-2031
Table 30. By Country - Europe Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Influenza Drugs and Vaccines Revenue, (US$, Mn), 2024-2031
Table 32. By Country - Europe Influenza Drugs and Vaccines Sales, (MT), 2019-2024
Table 33. By Country - Europe Influenza Drugs and Vaccines Sales, (MT), 2024-2031
Table 34. By Region - Asia Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Influenza Drugs and Vaccines Revenue, (US$, Mn), 2024-2031
Table 36. By Region - Asia Influenza Drugs and Vaccines Sales, (MT), 2019-2024
Table 37. By Region - Asia Influenza Drugs and Vaccines Sales, (MT), 2024-2031
Table 38. By Country - South America Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Influenza Drugs and Vaccines Revenue, (US$, Mn), 2024-2031
Table 40. By Country - South America Influenza Drugs and Vaccines Sales, (MT), 2019-2024
Table 41. By Country - South America Influenza Drugs and Vaccines Sales, (MT), 2024-2031
Table 42. By Country - Middle East & Africa Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Influenza Drugs and Vaccines Revenue, (US$, Mn), 2024-2031
Table 44. By Country - Middle East & Africa Influenza Drugs and Vaccines Sales, (MT), 2019-2024
Table 45. By Country - Middle East & Africa Influenza Drugs and Vaccines Sales, (MT), 2024-2031
Table 46. Bristol Myers Squibb Company Summary
Table 47. Bristol Myers Squibb Influenza Drugs and Vaccines Product Offerings
Table 48. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 49. Bristol Myers Squibb Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Influenza Drugs and Vaccines Product Offerings
Table 52. AstraZeneca Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Eli Lilly Company Summary
Table 55. Eli Lilly Influenza Drugs and Vaccines Product Offerings
Table 56. Eli Lilly Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 57. Eli Lilly Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche Influenza Drugs and Vaccines Product Offerings
Table 60. Roche Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 61. Roche Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Influenza Drugs and Vaccines Product Offerings
Table 64. GlaxoSmithKline Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Influenza Drugs and Vaccines Product Offerings
Table 68. Novartis Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 69. Novartis Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Influenza Drugs and Vaccines Product Offerings
Table 72. Pfizer Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 73. Pfizer Key News & Latest Developments
Table 74. Sanofi Pasteur Company Summary
Table 75. Sanofi Pasteur Influenza Drugs and Vaccines Product Offerings
Table 76. Sanofi Pasteur Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 77. Sanofi Pasteur Key News & Latest Developments
Table 78. Bayer Company Summary
Table 79. Bayer Influenza Drugs and Vaccines Product Offerings
Table 80. Bayer Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 81. Bayer Key News & Latest Developments
Table 82. Celgene Company Summary
Table 83. Celgene Influenza Drugs and Vaccines Product Offerings
Table 84. Celgene Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 85. Celgene Key News & Latest Developments
Table 86. Seqirus Company Summary
Table 87. Seqirus Influenza Drugs and Vaccines Product Offerings
Table 88. Seqirus Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 89. Seqirus Key News & Latest Developments
Table 90. Protein Sciences Corporation Company Summary
Table 91. Protein Sciences Corporation Influenza Drugs and Vaccines Product Offerings
Table 92. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 93. Protein Sciences Corporation Key News & Latest Developments
Table 94. Serum Institute of India Company Summary
Table 95. Serum Institute of India Influenza Drugs and Vaccines Product Offerings
Table 96. Serum Institute of India Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 97. Serum Institute of India Key News & Latest Developments
Table 98. Emergent Biosolutions Company Summary
Table 99. Emergent Biosolutions Influenza Drugs and Vaccines Product Offerings
Table 100. Emergent Biosolutions Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 101. Emergent Biosolutions Key News & Latest Developments
Table 102. BioCryst Pharmaceuticals Company Summary
Table 103. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Offerings
Table 104. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 105. BioCryst Pharmaceuticals Key News & Latest Developments
Table 106. Alvogen Company Summary
Table 107. Alvogen Influenza Drugs and Vaccines Product Offerings
Table 108. Alvogen Influenza Drugs and Vaccines Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 109. Alvogen Key News & Latest Developments
Table 110. Influenza Drugs and Vaccines Production Capacity (MT) of Key Manufacturers in Global Market, 2021-2024 (MT)
Table 111. Global Influenza Drugs and Vaccines Capacity Market Share of Key Manufacturers, 2021-2024
Table 112. Global Influenza Drugs and Vaccines Production by Region, 2019-2024 (MT)
Table 113. Global Influenza Drugs and Vaccines Production by Region, 2024-2031 (MT)
Table 114. Influenza Drugs and Vaccines Market Opportunities & Trends in Global Market
Table 115. Influenza Drugs and Vaccines Market Drivers in Global Market
Table 116. Influenza Drugs and Vaccines Market Restraints in Global Market
Table 117. Influenza Drugs and Vaccines Raw Materials
Table 118. Influenza Drugs and Vaccines Raw Materials Suppliers in Global Market
Table 119. Typical Influenza Drugs and Vaccines Downstream
Table 120. Influenza Drugs and Vaccines Downstream Clients in Global Market
Table 121. Influenza Drugs and Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Influenza Drugs and Vaccines Segment by Type in 2022
Figure 2. Influenza Drugs and Vaccines Segment by Application in 2022
Figure 3. Global Influenza Drugs and Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Influenza Drugs and Vaccines Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Influenza Drugs and Vaccines Revenue, 2019-2031 (US$, Mn)
Figure 7. Influenza Drugs and Vaccines Sales in Global Market: 2019-2031 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Influenza Drugs and Vaccines Revenue in 2022
Figure 9. By Type - Global Influenza Drugs and Vaccines Revenue, (US$, Mn), 2022 & 2031
Figure 10. By Type - Global Influenza Drugs and Vaccines Revenue Market Share, 2019-2031
Figure 11. By Type - Global Influenza Drugs and Vaccines Sales Market Share, 2019-2031
Figure 12. By Type - Global Influenza Drugs and Vaccines Price (USD/Kg), 2019-2031
Figure 13. By Application - Global Influenza Drugs and Vaccines Revenue, (US$, Mn), 2022 & 2031
Figure 14. By Application - Global Influenza Drugs and Vaccines Revenue Market Share, 2019-2031
Figure 15. By Application - Global Influenza Drugs and Vaccines Sales Market Share, 2019-2031
Figure 16. By Application - Global Influenza Drugs and Vaccines Price (USD/Kg), 2019-2031
Figure 17. By Region - Global Influenza Drugs and Vaccines Revenue, (US$, Mn), 2022 & 2031
Figure 18. By Region - Global Influenza Drugs and Vaccines Revenue Market Share, 2019 VS 2022 VS 2031
Figure 19. By Region - Global Influenza Drugs and Vaccines Revenue Market Share, 2019-2031
Figure 20. By Region - Global Influenza Drugs and Vaccines Sales Market Share, 2019-2031
Figure 21. By Country - North America Influenza Drugs and Vaccines Revenue Market Share, 2019-2031
Figure 22. By Country - North America Influenza Drugs and Vaccines Sales Market Share, 2019-2031
Figure 23. US Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 24. Canada Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 25. Mexico Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 26. By Country - Europe Influenza Drugs and Vaccines Revenue Market Share, 2019-2031
Figure 27. By Country - Europe Influenza Drugs and Vaccines Sales Market Share, 2019-2031
Figure 28. Germany Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 29. France Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 30. U.K. Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 31. Italy Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 32. Russia Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 33. Nordic Countries Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 34. Benelux Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 35. By Region - Asia Influenza Drugs and Vaccines Revenue Market Share, 2019-2031
Figure 36. By Region - Asia Influenza Drugs and Vaccines Sales Market Share, 2019-2031
Figure 37. China Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 38. Japan Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 39. South Korea Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 40. Southeast Asia Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 41. India Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 42. By Country - South America Influenza Drugs and Vaccines Revenue Market Share, 2019-2031
Figure 43. By Country - South America Influenza Drugs and Vaccines Sales Market Share, 2019-2031
Figure 44. Brazil Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 45. Argentina Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 46. By Country - Middle East & Africa Influenza Drugs and Vaccines Revenue Market Share, 2019-2031
Figure 47. By Country - Middle East & Africa Influenza Drugs and Vaccines Sales Market Share, 2019-2031
Figure 48. Turkey Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 49. Israel Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 50. Saudi Arabia Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 51. UAE Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2031
Figure 52. Global Influenza Drugs and Vaccines Production Capacity (MT), 2019-2031
Figure 53. The Percentage of Production Influenza Drugs and Vaccines by Region, 2022 VS 2031
Figure 54. Influenza Drugs and Vaccines Industry Value Chain
Figure 55. Marketing Channels
